The investment in the facilities and employee training will help meet the increasing global demand for OxyMem’s Membrane Aerated Biofilm Reactor (MABR) technology.
OxyMem, which was acquired by DuPont in 2019, was the first company to commercialise MABR technology, which provides unique and differentiated performance for secondary wastewater treatment.
“This investment will allow OxyMem to develop more efficient and more reliable production technology as well as improve our product design to meet the continuously increasing demand by the market” said Andreas Gorenflo, general manager of OxyMem. “It is fundamentally important, and it will help us grow the company to meet the increasing global demand for MABR.”
The project is supported by the Irish Government through IDA Ireland, a non-commercial, semi-state body promoting foreign direct investment into Ireland.
“This investment will have a transformative impact for the site and the staff, who will all benefit from upskilling. I was delighted to have the opportunity to visit the facility and see first-hand the excellent work being undertaken there. I wish the team the very best in this new chapter.” said Robert Troy, the Irish Government Minister for Trade Promotion, Digital and Company Regulation.
